|
|
Exchange: |
Nasdaq National Market |
Security
Type: |
Common |
Shares
Out: |
389,580,000 |
Market
Cap: |
49.62(B) |
Last
Volume: |
2,275,563 |
Avg
Vol: |
1,913,967 |
52
Week Range: |
$75.49 - $140.45 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Health Services |
Level
III Sector: |
Medical Instruments & Supplies |
|
Member Indexes:
|
NASDAQ COMPOSITE |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : 487 |
Guru Rank Value : 3 |
Guru Occurances : 1 |
|
|
|
|
|
|
|
Company Profile DexCom is a medical device company primarily focused on the design, development and commercialization of continuous glucose monitoring (CGM) systems. Co.'s product candidates include Dexcom G7®, which is designed with the goal of carrying forward many of the same features as Co.'s G6 CGM system and adding several new or improved features. Co.'s products include: DexCom G6® integrated Continuous Glucose Monitoring System (G6), which is a type of CGM system to be used as part of an integrated system with other medical devices and electronic interfaces; and DexCom Share®, which transmit glucose information to the cloud and then to apps on the mobile devices of up to five designated recipients.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
213,540 |
278,390 |
302,534 |
572,658 |
Total Sell Value |
$28,796,122 |
$36,739,208 |
$39,473,632 |
$69,793,485 |
Total People Sold |
7 |
9 |
14 |
15 |
Total Sell Transactions |
14 |
25 |
45 |
79 |
End Date |
2024-02-25 |
2023-11-24 |
2023-05-26 |
2022-05-26 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Flynn Paul R |
EVP, Global Revenue |
|
2021-04-15 |
4 |
AS |
$400.00 |
$303,200 |
D/D |
(758) |
12,306 |
|
29% |
|
Sayer Kevin R |
Chairman, CEO & President |
|
2021-04-05 |
4 |
AS |
$365.67 |
$2,281,082 |
D/D |
(6,221) |
111,257 |
|
34% |
|
Patterson Chad |
EVP, Global MarketingOfficer |
|
2021-03-31 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
10,177 |
|
39% |
|
Shrishrimal Sumi |
SVP Chief Risk OfficerOfficer |
|
2021-03-31 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
14,847 |
|
39% |
|
Flynn Paul R |
EVP, Global RevenueOfficer |
|
2021-03-31 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
13,064 |
|
39% |
|
Murphy Patrick Michael |
EVP, Chief Legal Officer |
|
2021-03-26 |
4 |
AS |
$350.00 |
$175,000 |
D/D |
(500) |
19,741 |
|
49% |
|
Pacelli Steven Robert |
Managing Dir., Dexcom Ventures |
|
2021-03-23 |
4 |
AS |
$352.88 |
$388,967 |
D/D |
(1,079) |
54,479 |
|
40% |
|
Doubleday Richard |
EVP Chief Commercial Officer |
|
2021-03-23 |
4 |
AS |
$352.88 |
$399,788 |
I/I |
(1,109) |
6,654 |
|
40% |
|
Augustinos Nicholas |
Director |
|
2021-03-18 |
4 |
D |
$0.00 |
$0 |
I/I |
(2,192) |
7,900 |
|
- |
|
Augustinos Nicholas |
Director |
|
2021-03-18 |
4 |
A |
$0.00 |
$0 |
D/D |
2,192 |
2,998 |
|
- |
|
Selvaraj Shelly Ramasamy |
SVP Information Technology |
|
2021-03-11 |
4 |
AS |
$355.86 |
$664,391 |
D/D |
(1,867) |
16,136 |
|
22% |
|
Leach Jacob Steven |
EVP Chief Technology Officer |
|
2021-03-10 |
4 |
S |
$362.92 |
$1,942,695 |
D/D |
(5,353) |
105,396 |
|
-26% |
|
Sylvain Jereme M |
SVP, Finance & CAO |
|
2021-03-10 |
4 |
S |
$362.92 |
$341,505 |
D/D |
(941) |
15,108 |
|
-26% |
|
Balo Andrew K |
* |
|
2021-03-10 |
4 |
S |
$362.92 |
$2,019,996 |
D/D |
(5,566) |
35,307 |
|
-26% |
|
Sayer Kevin R |
Chairman, CEO & President |
|
2021-03-10 |
4 |
S |
$362.92 |
$5,096,806 |
D/D |
(14,044) |
117,478 |
|
-26% |
|
Murphy Patrick Michael |
EVP, Chief Legal Officer |
|
2021-03-10 |
4 |
S |
$362.92 |
$1,259,685 |
D/D |
(3,471) |
20,241 |
|
-26% |
|
Abbey Donald |
EVP Quality and Regulatory Aff |
|
2021-03-10 |
4 |
S |
$362.92 |
$2,019,996 |
D/D |
(5,566) |
49,937 |
|
-26% |
|
Selvaraj Shelly Ramasamy |
SVP Information Technology |
|
2021-03-10 |
4 |
AS |
$362.92 |
$979,876 |
D/D |
(2,700) |
18,003 |
|
26% |
|
Blackford Quentin S. |
Chief Operating Officer & CFO |
|
2021-03-10 |
4 |
S |
$362.22 |
$2,357,688 |
D/D |
(6,509) |
45,165 |
|
-26% |
|
Pacelli Steven Robert |
EVP Strategy and Corporate Dev |
|
2021-03-10 |
4 |
S |
$362.92 |
$2,019,996 |
D/D |
(5,566) |
55,558 |
|
-26% |
|
Sayer Kevin R |
Chairman, CEO & President |
|
2021-03-09 |
4 |
AS |
$356.94 |
$1,392,796 |
D/D |
(3,857) |
131,522 |
|
20% |
|
Selvaraj Shelly Ramasamy |
SVP Information Technology |
|
2021-03-09 |
4 |
AS |
$356.94 |
$54,255 |
D/D |
(152) |
20,703 |
|
20% |
|
Sayer Kevin R |
Chairman, CEO & President |
|
2021-03-08 |
4 |
A |
$0.00 |
$13 |
D/D |
13,445 |
135,379 |
|
- |
|
Balo Andrew K |
* |
|
2021-03-08 |
4 |
A |
$0.00 |
$5 |
D/D |
5,301 |
40,873 |
|
- |
|
Selvaraj Shelly Ramasamy |
SVP Information Technology |
|
2021-03-08 |
4 |
A |
$0.00 |
$3 |
D/D |
3,073 |
20,855 |
|
- |
|
1713 Records found
|
|
Page 14 of 69 |
|
|